このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Shanghai Pioneer Holding 将来の成長
Future 基準チェック /06
現在、 Shanghai Pioneer Holdingの成長と収益を予測するのに十分なアナリストの調査がありません。
主要情報
n/a
収益成長率
n/a
EPS成長率
| Healthcare 収益成長 | 17.0% |
| 収益成長率 | n/a |
| 将来の株主資本利益率 | n/a |
| アナリストカバレッジ | None |
| 最終更新日 | n/a |
今後の成長に関する最新情報
Recent updates
Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024
Apr 24
Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024
Apr 03Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings
Apr 01Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks
Mar 22Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital
Feb 26Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?
Oct 21Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024
Sep 18Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024
Sep 01Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching
Aug 09Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year
Apr 14Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year
Mar 31Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly
Dec 15China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018
Sep 21China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year
Sep 02China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward
Jun 22China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064
Apr 14China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around
Jan 16These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely
Oct 11China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year
Sep 15China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056
Sep 01China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns
Aug 26Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture
May 22We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt
Apr 25Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?
Mar 14How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?
Feb 21
Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?
Feb 03Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?
Jan 16China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet
Dec 29Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?
Dec 14China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment
Nov 29このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Shanghai Pioneer Holding は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。
シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。
業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2023 | 1,567 | 146 | -163 | -119 | N/A |
| 9/30/2023 | 1,600 | 168 | -180 | -128 | N/A |
| 6/30/2023 | 1,634 | 190 | -198 | -137 | N/A |
| 3/31/2023 | 1,595 | 213 | -89 | -22 | N/A |
| 12/31/2022 | 1,556 | 235 | 19 | 93 | N/A |
| 9/30/2022 | 1,482 | 216 | 134 | 194 | N/A |
| 6/30/2022 | 1,408 | 196 | 250 | 296 | N/A |
| 3/31/2022 | 1,422 | 169 | 236 | 269 | N/A |
| 12/31/2021 | 1,435 | 143 | 222 | 242 | N/A |
| 9/30/2021 | 1,415 | 117 | 194 | 244 | N/A |
| 6/30/2021 | 1,395 | 91 | 166 | 246 | N/A |
| 3/31/2021 | 1,364 | 72 | 81 | 160 | N/A |
| 12/31/2020 | 1,332 | 52 | -4 | 74 | N/A |
| 9/30/2020 | 1,325 | 45 | -9 | 38 | N/A |
| 6/30/2020 | 1,318 | 37 | -15 | 2 | N/A |
| 3/31/2020 | 1,317 | 71 | 128 | 141 | N/A |
| 12/31/2019 | 1,316 | 105 | 272 | 281 | N/A |
| 9/30/2019 | 1,304 | 84 | 240 | 246 | N/A |
| 6/30/2019 | 1,293 | 63 | 208 | 212 | N/A |
| 3/31/2019 | 1,459 | 74 | 168 | 170 | N/A |
| 12/31/2018 | 1,624 | 85 | 128 | 129 | N/A |
| 9/30/2018 | 1,851 | 171 | 135 | 141 | N/A |
| 6/30/2018 | 2,077 | 258 | 142 | 153 | N/A |
| 3/31/2018 | 2,116 | 269 | 183 | 193 | N/A |
| 12/31/2017 | 2,154 | 279 | 223 | 234 | N/A |
| 9/30/2017 | 2,083 | 279 | N/A | 297 | N/A |
| 6/30/2017 | 2,012 | 280 | N/A | 361 | N/A |
| 3/31/2017 | 1,901 | 259 | N/A | 352 | N/A |
| 12/31/2016 | 1,790 | 237 | N/A | 342 | N/A |
| 9/30/2016 | 1,627 | 174 | N/A | 317 | N/A |
| 6/30/2016 | 1,464 | 111 | N/A | 292 | N/A |
| 3/31/2016 | 1,462 | 143 | N/A | 298 | N/A |
| 12/31/2015 | 1,461 | 174 | N/A | 305 | N/A |
| 9/30/2015 | 1,533 | 231 | N/A | 192 | N/A |
| 6/30/2015 | 1,605 | 287 | N/A | 79 | N/A |
| 3/31/2015 | 1,573 | 274 | N/A | 31 | N/A |
| 12/31/2014 | 1,540 | 262 | N/A | -18 | N/A |
| 9/30/2014 | 1,500 | 262 | N/A | -50 | N/A |
| 6/30/2014 | 1,460 | 263 | N/A | -82 | N/A |
| 3/31/2014 | 1,366 | 250 | N/A | -17 | N/A |
| 12/31/2013 | 1,272 | 238 | N/A | 48 | N/A |
| 9/30/2013 | 1,175 | 229 | N/A | 143 | N/A |
| 6/30/2013 | 1,077 | 220 | N/A | 238 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: 1345の予測収益成長が 貯蓄率 ( 2.2% ) を上回っているかどうかを判断するにはデータが不十分です。
収益対市場: 1345の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です
高成長収益: 1345の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。
収益対市場: 1345の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。
高い収益成長: 1345の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: 1345の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です